3304-module 1-

Upload: jesus-martinez

Post on 10-Apr-2018

258 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/8/2019 3304-Module 1-

    1/84

    NURS 3304PHARMACOTHERAPEUTICS

    Adrianne Linton PhD RN

    Jennie Shaw MSN RN

    Blackboard Assistance byMaryShannon Williams

  • 8/8/2019 3304-Module 1-

    2/84

    Course Objectives

    CourseObjectives

  • 8/8/2019 3304-Module 1-

    3/84

    Examinetheroleofdrugtherapyinrelationtohealthpromotion, diseasepreventionand managementacrossthelifespan. (Essential VII, IX)

    Incorporateunderstandingofdrug

    classificationsand actions. (Essential VII,IX)

    Identifyrelevantassessment data,

    appropriatenursinggoalsandintervention,and evaluation datarelatedto drugtherapy. (Essential IX)

  • 8/8/2019 3304-Module 1-

    4/84

    Identifytheneed forcustomizationofdrug

    therapy based onindividualpatientvariablesincludingphysiologic,psychosocial,genetic,cultural,patientbeliefsystem, knowledge baseandresources. (Essential VII, IX)

    Integrate knowledgeofphysicalandbehavioralscienceswithlegaland ethical

    guidelinestoplanforsafeand effectiveimplementationofpharmacotherapeutics.(Essential I, II, V, IX)

  • 8/8/2019 3304-Module 1-

    5/84

    Identifystrategiestoemployintraprofessionalcommunicationrelated to

    patients drugtherapy. (Essential VI, IX)Describehowthenursepreparespatientsand theirfamiliestomanageself-pharmacotherapeutics. (Essential VI, IX)

  • 8/8/2019 3304-Module 1-

    6/84

    Identifyinformationtechnologysourcesfortheacquisitionand applicationofevidence-based guidelinestopractice.

    (Essential III. IV, IX)

    Usecriticalthinkingprocesstoapplyknowledgeofpharmacologytoplansafe

    and effective drugtherapy. (Essential I, IX)

  • 8/8/2019 3304-Module 1-

    7/84

    DrugCalculations.

    The SchoolofNursinghasadoptedDimensional Analysisasthemethod of

    performingmath/

    drug

    calculations.

    Itisexpected thatyoualready know basicmathand youwillhaveanopportunitytoreviewthisskill.

  • 8/8/2019 3304-Module 1-

    8/84

    Criteria for Evaluation

    Grade Percentages:

    25%- Exam 125%- Exam230%- FinalExam10%- CurrentEvent Written Assignment10%- Blackboard Activitiesand

    Participation100% - Total

  • 8/8/2019 3304-Module 1-

    9/84

    TextbooksRequired Lehne, R. A. (2010) Pharmacology for Nursing Care

    (7thed.)

    Mulholland, JoyceM. (2007) The Nurse, The Math,The Meds: Drug Calculations using Dimensional

    Analysis

    Recommended

    Basch & Ulbright:Natural Standard Herb andSupplement Handbook(2005)

    Publication Manual of the American PsychologicalAssociation (2009)

  • 8/8/2019 3304-Module 1-

    10/84

    Equivalencies

    1 liter (L) = 1000 milliliters

    (mL)

    1 kilogram (kg) = 1000 grams 1 gram (g) = 1000 milligrams

    (mg)

    1 milligram (mg) = 1000micrograms (mcg)

  • 8/8/2019 3304-Module 1-

    11/84

    Equivalencies 1 tsp = 5 mL

    1 Tbsp = 15 mL

    1 ounce = 30 mL

    1 glass = 240 mL

    1 gr = 60, 64, or 65

    mg

    15 gr = 1 Gm 1 kg = 2.2 lbs

  • 8/8/2019 3304-Module 1-

    12/84

    Abbreviations

    cc oz IV

    g,gm, Gm ss OD

    gr T.O. OS

    gtt Unit OU

    kg V.O. PO

    L,l x (times) PR

    mcg, g < SC,subc,scmEq > Sl,sl

    Mg,mg ID Vag

    ml IM

  • 8/8/2019 3304-Module 1-

    13/84

    AbbreviationsAC PC STAT

    Ad lib PRN TID

    c Q,q

    H,h Q AM

    hs,HS QIDNPO s

  • 8/8/2019 3304-Module 1-

    14/84

    Do Not Use Abbreviations

    The JointCommission

    http://www.jointcommission.org

    Patient SafetyDo Not Use List

    National Patient Safety Goals

  • 8/8/2019 3304-Module 1-

    15/84

    PharmacologyPharmacology

    A sciencethat drawsoninformationfromA sciencethat drawsoninformationfrommultiple disciplines,including:multiple disciplines,including:AnatomyAnatomyPhysiologyPhysiologyPsychologyPsychologyChemistryChemistry

    MicrobiologyMicrobiology

  • 8/8/2019 3304-Module 1-

    16/84

  • 8/8/2019 3304-Module 1-

    17/84

    BasicTermsBasicTerms

    ClinicalpharmacologyClinicalpharmacologyStudyofdrugsinhumansStudyofdrugsinhumans

    TherapeuticsTherapeutics

    Theuseofdrugsto diagnose,prevent,Theuseofdrugsto diagnose,prevent,ortreat diseaseortopreventortreat diseaseortopreventpregnancy,ormoresimply: themedicalpregnancy,ormoresimply: themedical

    useofdrugsuseofdrugs

  • 8/8/2019 3304-Module 1-

    18/84

    Conventional Drugs

    Used in Westernmedicine

    Productionregulated

    Meetstandardsforsafetyand efficacy Includeprescriptionand OTCs

  • 8/8/2019 3304-Module 1-

    19/84

    Non-allopathic Agents Folk remedies

    Herbalsupplements

    Limited evidenceofsafetyandefficacy (butgrowing)

    Promoteconsumerchoiceand

    selftreatment

  • 8/8/2019 3304-Module 1-

    20/84

    USES OF DRUG THERAPYDrugs modify existing functions on a tissue orbody organ

    Drugs do not create new functions important to

    know this.

    Restorenormallevelofdeficientsubstances

    Block harmfulphysiologicprocesses

    Stimulatehealthyphysiologicprocesses

  • 8/8/2019 3304-Module 1-

    21/84

    USES (cont.)

    Destroypathogens

    Destroyabnormaltissue

    Protectvulnerabletissue-sunscreenex,creams

    toprotecttheskin Eliminateexcessorharmfulsubstances-

    direutics,

    Reducesymptoms-exTylenol.

  • 8/8/2019 3304-Module 1-

    22/84

    FUNDAMENTAL PRINCIPLES

    All drugs are potential poisons when

    taken in sufficiently high doses

    No drug produces one, and only one,effect

  • 8/8/2019 3304-Module 1-

    23/84

    Orientationto PharmacologyOrientationto Pharmacology

    Propertiesofanideal drugThetherapeuticobjectiveFactorsthat determinetheintensityof

    drugresponsesTherapeutics

  • 8/8/2019 3304-Module 1-

    24/84

    ThreeMost ImportantThreeMost ImportantPropertiesofan Ideal DrugPropertiesofan Ideal Drug

    1.1.EffectivenessEffectiveness--doeswhatissupposeto dodoeswhatissupposeto do2.2. SafetySafety--thereisnosuchthingasasafethereisnosuchthingasasafe

    drugdrug3.3. SelectivitySelectivity--meaningthatit doesnt ONLYmeaningthatit doesnt ONLY

    whatitsmeantto do,BUT NO SUCHwhatitsmeantto do,BUT NO SUCHDRUG EXISTS.DRUG EXISTS.

  • 8/8/2019 3304-Module 1-

    25/84

    Additional Propertiesofan Ideal DrugAdditional Propertiesofan Ideal Drug

    Reversibleaction-ex. Anethesia,morphinePredictability-cant betotallypredicted,

    everyoneis different.Easeofadministration-expill,insulin by

    injection,Freedomfrom druginteractions-

    Lowcost-Chemicalstability-Simplegenericname-

    But becauseno drugisideal

  • 8/8/2019 3304-Module 1-

    26/84

    Therapeutic ObjectiveofTherapeutic ObjectiveofDrugTherapyDrugTherapy

    Providemaximum benefitwithProvidemaximum benefitwithminimumharmminimumharm

  • 8/8/2019 3304-Module 1-

    27/84

    FactorsThat Determinethe IntensityofFactorsThat Determinethe IntensityofDrug ResponsesDrug Responses

    AdministrationAdministration--PharmacokineticsPharmacokinetics--how drugsmovehow drugsmove

    throughyourbodythroughyourbodyPharmacodynamicsPharmacodynamics--how dotheyworkhow dotheyworkSourcesofindividualvariationSourcesofindividualvariation

  • 8/8/2019 3304-Module 1-

    28/84

    Fig. 1-1.The four basic pharmacokinetic processes.Dotted linesrepresentmembranesthatmust becrossed as drugsmovethroughoutthe body.

  • 8/8/2019 3304-Module 1-

    29/84

    AdministrationAdministration

    Important determinantsofdrugresponses:Important determinantsofdrugresponses:dosagesize,route,timingdosagesize,route,timing

    MedicationerrorsMedicationerrorsPatientadherencePatientadherence

  • 8/8/2019 3304-Module 1-

    30/84

    PharmacokineticsPharmacokinetics

    DetermininghowmuchofadministeredDetermininghowmuchofadministereddosegetstoitssitesofactiondosegetstoitssitesofaction

    Impactofthe bodyon drugsImpactofthe bodyon drugsFourmajorpharmacokineticprocesses:Fourmajorpharmacokineticprocesses:DrugabsorptionDrugabsorptionDrug distributionDrug distributionDrugmetabolismDrugmetabolismDrugexcretionDrugexcretion

  • 8/8/2019 3304-Module 1-

    31/84

    PharmacodynamicsPharmacodynamics

    Impactofdrugsonthe bodyImpactofdrugsonthe bodyDrugDrug--receptorinteractionreceptorinteractionBindingofthe drugtoitsreceptorBindingofthe drugtoitsreceptor

  • 8/8/2019 3304-Module 1-

    32/84

    Sourcesof Individual VariationSourcesof Individual Variation

    PhysiologicvariablesPhysiologicvariablesAge,gender,weightAge,gender,weight

    PathologicvariablesPathologicvariablesDiminished functionofkidneysand liverDiminished functionofkidneysand liver

    GeneticvariablesGeneticvariablesCanaltermetabolismofdrugsand predisposeCanaltermetabolismofdrugsand predisposepatienttouniqueinteractionspatienttouniqueinteractions

    DruginteractionsDruginteractions

  • 8/8/2019 3304-Module 1-

    33/84

    Key PointsKey Points

    Thereisnosuchthingasasafe drug;allThereisnosuchthingasasafe drug;alldrugscancauseharm.drugscancauseharm.

    Thereisnosuchthingasaselective drug;Thereisnosuchthingasaselective drug;all drugscancausesideeffects.all drugscancausesideeffects.

    TheobjectiveofdrugtherapyistoprovideTheobjectiveofdrugtherapyistoprovidemaximum benefitwithminimumharm.maximum benefitwithminimumharm.

    Becauseallpatientsareunique, drugBecauseallpatientsareunique, drugtherapymust betailored toeachtherapymust betailored toeachindividual.individual.

  • 8/8/2019 3304-Module 1-

    34/84

    Chapter2Chapter2

    ApplicationofPharmacologyinApplicationofPharmacologyinNursing PracticeNursing Practice

  • 8/8/2019 3304-Module 1-

    35/84

    Nursing Responsibilities Regarding DrugsNursing Responsibilities Regarding Drugs

    Thenursemust knowThenursemust knowWhatmedicationsareappropriateforWhatmedicationsareappropriatefor

    thepatientthepatientWhat drugsarecontraindicated fortheWhat drugsarecontraindicated forthepatientpatient

    TheprobableconsequencesoftheTheprobableconsequencesofthe

    interaction between drugand patientinteraction between drugand patient

  • 8/8/2019 3304-Module 1-

    36/84

    Nursing Responsibilities Regarding DrugsNursing Responsibilities Regarding Drugs

    zz Correctadministration,withoutCorrectadministration,withoutadditionalinterventions,cannotensureadditionalinterventions,cannotensure

    thattreatmentwillresultinthethattreatmentwillresultinthetherapeuticobjective.therapeuticobjective.--zz TherapeuticobjectiveistoprovideTherapeuticobjectiveistoprovidemaximum benefitwithminimalharm.maximum benefitwithminimalharm.

  • 8/8/2019 3304-Module 1-

    37/84

    Nursing Responsibilities Regarding DrugsNursing Responsibilities Regarding Drugs

    ThenursesroleasadvocateThenursesroleasadvocateFollowsthepatientsstatusmostcloselyFollowsthepatientsstatusmostcloselyFirstmemberofthehealthcareteamtoFirstmemberofthehealthcareteamto

    observeand evaluate drugresponsesandobserveand evaluate drugresponsesandinterveneifrequiredinterveneifrequiredMust knowtheresponsethatamedicationisMust knowtheresponsethatamedicationis

    likelytoelicitlikelytoelicit

    LastlineofdefenseforthepatientLastlineofdefenseforthepatient--lastpersonlastpersonthepatientcancountonthepatientcancounton

  • 8/8/2019 3304-Module 1-

    38/84

    Pharmacologyin PatientCare

    Nurseresponsibilityand

    accountability

    Patienthasacardiacarrestafterreceivingarapid infusionofpotassium.-

  • 8/8/2019 3304-Module 1-

    39/84

    Nurse Responsibilityand Accountability

    Pregnantwomanhasapreservativeinstead

    ofananesthetic druginjected intoherspinalcolumn. Sheistotallyparalyzed and

    diesseveralmonthslater.

    NICU babies die

    afteroverdoseofheparin.

  • 8/8/2019 3304-Module 1-

    40/84

    As a nurse you are responsible for

    every drug that you administer.

  • 8/8/2019 3304-Module 1-

    41/84

    The Nursing Processguidesthenurseinadministering drugssafely.

  • 8/8/2019 3304-Module 1-

    42/84

    The Nursing Process

    Assessment

    Nursing Diagnosis

    Planning/GoalsInterventions

    Evaluation

  • 8/8/2019 3304-Module 1-

    43/84

    Assessment: Patient- this always

    happens FIRST

    Currentstatus-levelofconscious

    Past (health) history

    Medicationhistory

    Allergies

  • 8/8/2019 3304-Module 1-

    44/84

    Assessment: Patient

    Identifyinghigh-risk patientsLiverand kidneyimpairmentGeneticfactorsDrugallergiesPregnancyElderlyand pediatrics

    Tools:patienthistory,physicalexam,and lab results

  • 8/8/2019 3304-Module 1-

    45/84

  • 8/8/2019 3304-Module 1-

    46/84

    Assessment: Delivery systemDrugadministrationand security

    Drughandling

    Dosagemeasuring

    Obtainingthe drug

    Systemsused to dispensethe drug

    Howto document drugtherapyontheMAR (medicationadministrationrecord)

  • 8/8/2019 3304-Module 1-

    47/84

    Nursing DiagnosesAcute pain related totissue

    traumaand reflexmusclespasms

    secondarytosurgeryasevidencedbygrimacing,reluctancetogetoutofbed,and apainscoreof8.

    Risk for injury related tosedatingeffectsofopioid analgesics

  • 8/8/2019 3304-Module 1-

    48/84

    Planning/Setting Goals

    Patientwillhavepainlevelof3 orlesswithin 30 minutesofadministrationofmorphine

    Patientwillremainsafeafterpainmedicationisadministered asevidenced bynofallsorinjuriestoday

  • 8/8/2019 3304-Module 1-

    49/84

    Interventions:Drug Administration

    Six rights

    Patient 2identifiers!

    Drug

    Dose

    Route

    Time

    Right documentationrighttorefuse

    Isthisenoughtomeetthe

    therapeuticobjective?

  • 8/8/2019 3304-Module 1-

    50/84

    Interventions:Drug Administration

    Keepmedicationsecure-Be knowledgeableaboutinstitutionspoliciesand procedures

    Neveradministermedicationprepared byanothernurse-

    Nursemustobservepatienttaking

    medication-

  • 8/8/2019 3304-Module 1-

    51/84

    Interventions:Drug Administration

    Certain drugshavemorethanoneindication. Dosagemay differdependingonwhichindicationthe drugisused for.

    Many drugscan beadministered bymorethanoneroute. Dosagemay differdependingontherouteselected.

    Certain IV agentscancauseseverelocalinjuryif IV extravasates.

  • 8/8/2019 3304-Module 1-

    52/84

    Interventions:

    DocumentationWhentochart-doitimmediatelyafteryougivemeds.

    Wheretochart-

    Whattochart

    Whygivenornot (PRN vsroutine)

    Effects

    Otherrelevant data

  • 8/8/2019 3304-Module 1-

    53/84

  • 8/8/2019 3304-Module 1-

    54/84

    Interventions:

    Teaching

    Considerations

    KnowledgeReadinessto

    learn

    Environment

  • 8/8/2019 3304-Module 1-

    55/84

    TeachingMay Include

    Drug

    Schedule

    TherapeuticeffectsAdverseeffects

    Interactions

    Handling/storage

    Effectsofsuddenlydiscontinuing

    Whatifdosemissed

    Safetyconsiderations

  • 8/8/2019 3304-Module 1-

    56/84

    Evaluation

    OfDrugEffects

    Therapeuticresponse

    Adverseeffect (includessideeffects)

    Interactiveeffects

    Furtherteachingneeds

  • 8/8/2019 3304-Module 1-

    57/84

    PromotingTherapeuticEffectsPromotingTherapeuticEffects

    PromotingpatientadherencePromotingpatientadherenceAlso knownascomplianceorconcordanceAlso knownascomplianceorconcordanceExtenttowhichapatients behaviorcoincidesExtenttowhichapatients behaviorcoincides

    withmedicaladvicewithmedicaladvice ImplementingnondrugmeasuresImplementingnondrugmeasuresDrugtherapycanoften beenhanced byDrugtherapycanoften beenhanced by

    nondrugmeasures.nondrugmeasures.

    Biofeedback,emotionalsupport,weightBiofeedback,emotionalsupport,weightreduction,smokingcessation,sodiumreduction,smokingcessation,sodiumrestriction,etc.restriction,etc.

  • 8/8/2019 3304-Module 1-

    58/84

    Minimizing AdverseEffectsMinimizing AdverseEffects

    All drugshavethepotentialtoproduceAll drugshavethepotentialtoproduceundesired effects.undesired effects.

    Always knowthefollowing:Always knowthefollowing:Themajoradverseeffectsthe drugcanThemajoradverseeffectsthe drugcanproduceproduce

    ThetimewhenthesereactionsarelikelytoThetimewhenthesereactionsarelikelytooccuroccur

    EarlysignsthatanadversereactionisEarlysignsthatanadversereactionisdevelopingdeveloping

    Interventionsthatcanminimize discomfortandInterventionsthatcanminimize discomfortandharmharm

  • 8/8/2019 3304-Module 1-

    59/84

    Minimizing Adverse InteractionsMinimizing Adverse Interactions

    Takeathorough drughistory.Takeathorough drughistory.Advisethepatienttoavoid OTC drugsthatAdvisethepatienttoavoid OTC drugsthat

    caninteractwiththeprescribedcaninteractwiththeprescribedmedication.medication.

    MonitorforadverseinteractionsMonitorforadverseinteractionsknownknown totooccur.occur.

    BealertforasBealertforas--yetyetunknownunknown interactions.interactions.

  • 8/8/2019 3304-Module 1-

    60/84

    Making PRN DecisionsMaking PRN Decisions

    PRNPRN pprorenata,meaningasneededrorenata,meaningasneededKnowthereasonfordruguse.Knowthereasonfordruguse.BeabletoassessthepatientsmedicationBeabletoassessthepatientsmedication

    needs.needs.

  • 8/8/2019 3304-Module 1-

    61/84

    ManagingToxicityManagingToxicity

    EarlyidentificationmakesearlyEarlyidentificationmakesearlyinterventionpossible.interventionpossible.

    Knowtheearlysignsoftoxicity.Knowtheearlysignsoftoxicity.KnowtheprocedurefortoxicityKnowtheprocedurefortoxicitymanagement.management.

  • 8/8/2019 3304-Module 1-

    62/84

  • 8/8/2019 3304-Module 1-

    63/84

    OverviewofChapter3OverviewofChapter3

    Landmark druglegislationNew drug developmentDrugnamesOver-the-counterdrugsSourcesofdruginformation

  • 8/8/2019 3304-Module 1-

    64/84

  • 8/8/2019 3304-Module 1-

    65/84

    Food Drugand Cosmetic Act (1938) Targeted safetyand efficacy

    Regulated manufacture, distribution,advertising,labeling

    Made USP officialstandard forstrengthand purity

    www.usp.org

  • 8/8/2019 3304-Module 1-

    66/84

    Food Drugand Cosmetic Act (1938)

    Designated FDA toenforce

    RoleoftheFDA

    http://www.fda.gov/

  • 8/8/2019 3304-Module 1-

    67/84

    HarrisKefauverAmendment

    Firstlawto demand that drugsactuallyoffersome benefit

  • 8/8/2019 3304-Module 1-

    68/84

    Comprehensive Drug AbusePreventionand Control Act (1970)

    Classified and regulated drugswithpotentialforabuse

    Established drugabuseeducationandtreatmentprograms

    Reallyfocusonthis ACT ***

  • 8/8/2019 3304-Module 1-

    69/84

    Schedule 1: highabusepotential,noapproved medicaluse

    Schedule2: highabusepotential,accepted medicaluse-codeine,anabolicsteroids

    Schedule 3:lessabusepotential,accepted medicaluse

    Schedule 4:someabusepotential,

    accepted medicaluseSchedule5:lessabusepotentialthan

    schedule 4,accepted medicaluse

    Good ideato knowtheseschedules ***

  • 8/8/2019 3304-Module 1-

    70/84

    1992 Rx Drug UserFee Act

    Shortened review process

    1997 FDA Modernization Act

    Permitted drug companies to provide

    information about non-FDA approveduses ( off-label uses)-you CANT market a drug

    for a USE that is not approved by the FDA. You canshare the information, thats all.

  • 8/8/2019 3304-Module 1-

    71/84

    New Drug DevelopmentNew Drug Development

    Therandomized controlled trialTherandomized controlled trialControluseControluseRandomizationRandomization

    BlindingBlinding

  • 8/8/2019 3304-Module 1-

    72/84

    StagesofNew Drug DevelopmentStagesofNew Drug Development

    PreclinicaltestingPreclinicaltestingClinicaltestingClinicaltesting

    Phase 1: healthysubjects

    Phase2: targetgroupPhase 3: largertargetgroup

    Phase 4: FDA evaluationand

    postmarketing surveillance***Knowthesesteps. *** usuallyan 8 yearprocess.***Knowthesesteps. *** usuallyan 8 yearprocess.

  • 8/8/2019 3304-Module 1-

    73/84

    LimitationsoftheTesting ProcedureLimitationsoftheTesting Procedure

    Limited informationforwomenandLimited informationforwomenandchildrenchildrenWomenWomen

    ChildrenChildrenFailureto detectalladverseeffectsFailureto detectalladverseeffects

  • 8/8/2019 3304-Module 1-

    74/84

    Exercising Discretion RegardingExercising Discretion RegardingNew DrugsNew Drugs

    BeneitherthefirsttoadoptthenewnorBeneitherthefirsttoadoptthenewnorthelasttoabandontheold.thelasttoabandontheold.

    Balancepotential benefitsagainstinherentBalancepotential benefitsagainstinherent

    risks.risks.New drugsgenerallypresentgreaterrisksNew drugsgenerallypresentgreaterrisks

    thantheold ones.thantheold ones.

  • 8/8/2019 3304-Module 1-

    75/84

  • 8/8/2019 3304-Module 1-

    76/84

    Which Nameto UseWhich Nameto UseGenericorTrade?GenericorTrade?

    ThelittleproblemswithgenericnamesThelittleproblemswithgenericnamesMorecomplicated thantradenamesMorecomplicated thantradenames

    The bigproblemswithtradenamesThe bigproblemswithtradenames

    Single drugcanhavemultipletradenames.Single drugcanhavemultipletradenames.U.S. drugsand drugsoutsidethe U.S.mayU.S. drugsand drugsoutsidethe U.S.may

    have differentactiveingredients.have differentactiveingredients.ProductswiththesametradenamemayhaveProductswiththesametradenamemayhave

    differentactiveingredients.differentactiveingredients.Monistatand KaopectateMonistatand Kaopectate

  • 8/8/2019 3304-Module 1-

    77/84

  • 8/8/2019 3304-Module 1-

    78/84

    Which Nameto UseWhich Nameto UseGenericorTrade?GenericorTrade?

    Genericproductsversus brandGenericproductsversus brand--namenameproductsproductsAregenericproductsand brandAregenericproductsand brand--nameproductsnameproducts

    therapeuticallyequivalent?therapeuticallyequivalent?Would a difference between brandWould a difference between brand--nameandnameand

    genericproducts justifytheuseoftradenames?genericproducts justifytheuseoftradenames?

  • 8/8/2019 3304-Module 1-

    79/84

    OverOver--thethe--CounterDrugsCounterDrugs

    Americansspend about $20 billionAmericansspend about $20 billionannuallyon OTC drugs.annuallyon OTC drugs.

    OTC drugsaccountfor60%ofall dosesOTC drugsaccountfor60%ofall doses

    administered.administered.40%ofAmericanstakeatleastone OTC40%ofAmericanstakeatleastone OTC

    drugevery2 days.drugevery2 days.

    FourtimesasmanyillnessesaretreatedFourtimesasmanyillnessesaretreatedbyaconsumerusingan OTC drugas byabyaconsumerusingan OTC drugas byaconsumervisitingaphysician.consumervisitingaphysician.

  • 8/8/2019 3304-Module 1-

    80/84

    OverOver--thethe--CounterDrugsCounterDrugs

    Withmostillnesses (60%to 95%),initialWithmostillnesses (60%to 95%),initialtherapyconsistsofselftherapyconsistsofself--care,includingcare,includingselfself--medicationwithan OTC drug.medicationwithan OTC drug.

    TheaveragehomemedicinecabinetTheaveragehomemedicinecabinetcontains24 OTCpreparations.contains24 OTCpreparations.

  • 8/8/2019 3304-Module 1-

    81/84

    SourcesofDrug InformationSourcesofDrug Information

    PeoplePeopleCliniciansand pharmacistsCliniciansand pharmacistsPoisoncontrolcentersPoisoncontrolcenters

    PharmaceuticalsalesrepresentativesPharmaceuticalsalesrepresentatives

  • 8/8/2019 3304-Module 1-

    82/84

    Published InformationPublished Information

    TextText--like bookslike booksGoodman & Gilmans,The PharmacologicalGoodman & Gilmans,The Pharmacological

    BasisofTherapeuticsBasisofTherapeutics

    Pharmacotherapy: A PathophysiologicPharmacotherapy: A PathophysiologicApproachApproachApplied Therapeutics:TheClinical UseofApplied Therapeutics:TheClinical Useof

    DrugsDrugs

  • 8/8/2019 3304-Module 1-

    83/84

    Published InformationPublished Information

    NewslettersNewslettersTheMedical Letteron Drugsand TherapeuticsTheMedical Letteron Drugsand TherapeuticsPrescribers LetterPrescribers Letter

    Reference booksReference booksPhysicians Desk ReferencePhysicians Desk ReferenceDrugFactsand ComparisonsDrugFactsand ComparisonsNursing drugreferencesNursing drugreferences

  • 8/8/2019 3304-Module 1-

    84/84